The Methodist Hospital Research Institute

Rose Khavari

Professor of urology, 3 Sept 2026, reporter.nih.gov

Rachel A High

3 Sept 2026, reporter.nih.gov

Hina Faisal

24 Jul 2026, reporter.nih.gov

Elvin Blanco

Assistant professor, 28 Apr 2026, reporter.nih.gov

Katarzyna A. Cieslik

Scientist, 8 Apr 2026, reporter.nih.gov

Henry J. Pownall

11 Mar 2026, reporter.nih.gov

Khurram Nasir

11 Mar 2026, reporter.nih.gov

Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer

Phase 2, Not yet recruiting, 2027, 48 people, 15 Sept 2026, clinicaltrials.gov

NCT07651319

Phase 1/2, Recruiting, 2026, 30 people, 16 Jun 2026, clinicaltrials.gov

NCT07554417

Collaborator, Phase 4, Not yet recruiting, 2026, 20 people, 28 Apr 2026, clinicaltrials.gov

NCT07197749

Collaborator, Early phase 1, Not yet recruiting, 2026, 35 people, 29 Sept 2025, clinicaltrials.gov

Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker

Phase 2, Recruiting, 2026, 112 people, 11 Jul 2025, clinicaltrials.gov

NCT06930690

Phase 1/2, Recruiting, 2026, 70 people, 16 Apr 2025, clinicaltrials.gov

Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer

Phase 1, Recruiting, 2024, 33 people, 19 Feb 2025, clinicaltrials.gov

Deep Learning Enhanced Detection of Aortic Stenosis - The DETECT-AS-Diagnostic Study

Collaborator, No phase, Enrolling by invitation, 2025, 410 people, 27 Dec 2024, clinicaltrials.gov

NCT04740580

Collaborator, Early phase 1, Active, not recruiting, 2022, 52 people, 5 Feb 2021, clinicaltrials.gov

NCT04093648

Collaborator, Phase 1, Withdrawn, 2020, 0 people, 18 Sept 2019, clinicaltrials.gov

NCT03493178

Collaborator, Early phase 1, Active, not recruiting, 2018, 60 people, 10 Apr 2018, clinicaltrials.gov

NCT02988986

Phase 2, Completed, 2017, 28 people, 12 Dec 2016, clinicaltrials.gov

NCT02905188

Collaborator, Phase 1, Completed, 2019, 9 people, 19 Sept 2016, clinicaltrials.gov

NCT02834403

Phase 1/2, Completed, 2016, 37 people, 15 Jul 2016, clinicaltrials.gov

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

Collaborator, Phase 1, Completed, 2015, 35 people, 5 Mar 2015, clinicaltrials.gov

NCT02287311

Collaborator, Phase 1, Active, not recruiting, 2015, 38 people, 10 Nov 2014, clinicaltrials.gov

NCT02068092

Phase 2/3, Completed, 2013, 51 people, 21 Feb 2014, clinicaltrials.gov

NCT02067416

Collaborator, Phase 2, Withdrawn, 2012, 0 people, 20 Feb 2014, clinicaltrials.gov

NCT01931163

Collaborator, Phase 2, Completed, 2013, 24 people, 29 Aug 2013, clinicaltrials.gov

NCT01898221

Phase 3, Completed, 2013, 343 people, 12 Jul 2013, clinicaltrials.gov

National Institute on Aging

R01, Identification of Age and Sex Dependent Contributions to Supraspinal Mechanisms Involved in Underactive Bladder, R01AG094133, US$665.6k, 2026–2031, 3 Sept 2026, reporter.nih.gov

National Institute on Aging

K76, Virtual Reality-Based Cognitive Stimulation Games for Enhancing Attention and Preventing Delirium in Older Surgical Patients with Cognitive Impairment: A Randomized Controlled Pilot Trial, K76AG088424, US$242.8k, 2025–2030, 24 Jul 2026, reporter.nih.gov

National Eye Institute

R56, Mitochondrial factories for AMD therapy, R56EY036406, US$1m, 2026–2028, 28 Apr 2026, reporter.nih.gov

National Institute on Aging

R01, Proteomics based mapping of cardiac extracellular matrix to define sex and age-dependent changes., R01AG080925, US$621.8k, 2023–2028, 8 Apr 2026, reporter.nih.gov

National Heart, Lung, and Blood Institute

R01, Human Atherogenesis with Underlying Dysfunctional HDL-Free Cholesterol, R01HL163535, US$733.2k, 2023–2027, 11 Mar 2026, reporter.nih.gov